HUMABS

humabs-logo

Humabs currently has two clinical-stage partnered programs, validating the CellClone technologies and generating a significant revenue stream Humabs has a broad partnership with MedImmune, the global biologics research and development arm of AstraZeneca, that covers multiple pathogens. The most advanced of the projects is an antibody directed against influenza A virus. This antibody, called MEDI8852, has demonstrated activity against all known subtypes of the influenza A virus and is therefore... less affected by the emergence of new strains. The program was partnered with MedImmune while still in preclinical development and has currently concluded the clinical phase 1b/2a. Data on this program have been published in the journals Science and Cell. Humabs has also partnered with Novartis for an antibody directed against an undisclosed target. This program is currently in phase 2.

#Website #More

HUMABS

Social Links:

Industry:
Biotechnology Health Care Medical

Address:
Bellinzona, Ticino, Switzerland

Country:
Switzerland

Website Url:
http://www.humabs.com

Status:
Active

Contact:
+41918256380

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online Office 365 Mail


Official Site Inspections

http://www.humabs.com

  • Host name: ec2-34-192-255-123.compute-1.amazonaws.com
  • IP address: 34.192.255.123
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Humabs"

HUMABS | Home

Humabs has also a portfolio of programs to address major public health threats, such as Ebola, Zika, Rabies and Dengue. Highlights. Subsidiary of Vir Biotechnology, a San Francisco-based company, integrating diverse …See details»

Humabs - Crunchbase Company Profile & Funding

Humabs currently has two clinical-stage partnered programs, validating the CellClone technologies and generating a significant revenue stream. Humabs has a broad partnership …See details»

Humabs BioMed - Devex

Humabs BioMed is a private antibody therapeutics biotechnology company based in Switzerland spin-off from the Institute of Biomedical Research (IRB), Bellinzona, with which Humabs has a …See details»

Humabs | Funding, Valuation & Investors | Finallot

Humabs currently has two clinical-stage partnered programs, validating the CellClone technologies and generating a significant revenue stream Humabs has a broad partnership …See details»

Humabs BioMed AG - Swiss Biotech

Humabs BioMed, a subsidiary of Vir Biotechnology, uses its immunologic expertise and cutting-edge technology to combat infectious diseases and other serious conditions. ... Type of …See details»

Humabs BioMed SA - Drug pipelines, Patents, Clinical trials

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into …See details»

Humabs BioMed - Swiss Biotech

Humabs BioMed, a pioneer in the discovery, engineering, and early development of human monoclonal antibodies to fight infectious diseases. As a wholly owned subsidiary of Vir Biotechnology (Nasdaq: VIR), Humabs BioMed and its …See details»

Humabs LLC - Drug pipelines, Patents, Clinical trials - Synapse

Explore Humabs LLC with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Infectious Diseases, Technology Platform:Polyclonal antibody, Drug ...See details»

Humabs BioMed SA (Humabs BioMed SA) - 药物管线_专利_临床试 …

Recent scientific studies in this area have been led by the labs of David Veesler, associate professor of biochemistry at the University of Washington in Seattle and Howard Hughes …See details»

Humabs - Crunchbase

Humabs is using its cutting-edge proprietary technologies to discover new treatments against a variety of viral and bacterial infections. Search Crunchbase. Start Free Trial . Chrome …See details»

Vir Biotechnology acquires Humabs - 2017-09-25 - Crunchbase

Humabs Humabs is using its cutting-edge proprietary technologies to discover new treatments against a variety of viral and bacterial infections. Acquiring Organization: Vir Biotechnology Vir …See details»

Antonio Lanzavecchia, M.D. | Vir Biotechnology

Dr. Lanzavecchia is the Founding Director of the Institute for Research in Biomedicine in Bellinzona, Switzerland and the Scientific Founder of Humabs BioMed SA, a Switzerland …See details»

Humabs BioMed - Scientist.com

Humabs BioMed Via Mirasole 1 Bellinzona, , 6500 Switzerland: Get started If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If …See details»

Humabs | Company | RadialReport

Humabs Company. Industry: Biotechnology. Visit Website Register and Claim Ownership ...See details»

Broadly potent spike-specific human monoclonal antibodies

Oct 2, 2024 Four HuMabs had kappa light chains (K501SP1, K501SP2, K501SP3, and K501SP5) whereas three HuMabs had lambda light chains (K501SP4, K501SP6 and …See details»

Humabs - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Humabs is using its cutting-edge proprietary technologies to discover new treatments against a variety of viral and bacterial infections. Search Crunchbase. Start Free Trial . Chrome …See details»

Modern Hormone Treatments for both Men and Women | Science …

Therapies for Low testosterone level, Womens Hormone, Weight loss, Longevity Hairloss Treatment and Sexual Wellness for Men. We transform lives through scientifically-proven …See details»

Build a smarter Small Business - huumans inc.

We manage all the things you need to build a smarter Small Business.. Hundreds of Small Businesses - of all shapes and sizes - use us to help run their finances, payroll, strategy, …See details»

Humanbees Homepage - Humanbees

Human Bees provides workforce recruiting, staffing, and human capital solutions across multiple industries to secure time critical, temporary staff augmentation demands at a fraction of the cost.See details»

Human Organization - Taylor & Francis Online

Oct 11, 2024 Human Organization is the journal of the Society for Applied Anthropology and the leading peer reviewed outlet for scholarship in the applied social sciences. The journal …See details»